[ET Net News Agency, 8 December 2025] HSBC lowered the target price for Giant Biogene
(02367) to HKD46.4 from HKD69.3 and maintained the "buy" rating.
The research house said it cuts 2025e-27e earnings by 17-25% on Comfy brand growth
pressure. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02367 GIANT BIOGENE
Nominal 
35.980 -0.420 (-1.154%) Others
08/12/2025 16:04
{I-bank focus}HSBC lowers Giant Biogene (02367) to HKD46.4
Next︰03/12/2025 14:41 {I-bank focus}Citi lowers Giant Biogene (02367) to HKD44.6
02/12/2025 14:00 {Hot Stocks}GIANT BIOGENE quoted at HK$40.42, up 10.5%
23/10/2025 09:45 {Hot Stocks}GIANT BIOGENE quoted at HK$42.92, up 11.1%
16/10/2025 09:31 {Hot Stocks}3 listed firms see price swing at 9:30am
26/09/2025 09:01 {Block Trade}Trading session block trades at 9:00am
24/09/2025 14:12 {Hot Stocks}GIANT BIOGENE quoted at HK$55.5, down 9.7%
| Remark: | Real time quote last updated: 09/12/2025 13:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |